Halt Medical Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Halt Medical Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011157
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Halt Medical Inc (Halt Medical) is a healthcare service center that develops, manufactures and commercializes medical treatment for women with symptomatic uterine fibroids. The center offers Acessa System, a minimally invasive laparoscopic outpatient procedure to treat uterine fibroids. It offers products for treatment of percutaneous, laparoscopic coagulation, ablation of soft tissue, and symptomatic uterine fibroids under laparoscopic ultrasound guidance. Halt Medical offers services such as heavy menstrual bleeding, pain, bloating, and other debilitating fibroid symptoms detection and treatment, multi centre clinical trials, invasive surgical procedures, fibroids treatment services, clinical studies, and uterine-conserving study procedures. Its technologies include radiofrequency volumetric thermal ablation, fibroid treatment algorithm, and laparoscopic ultrasound in fibroid treatment. Halt Medical is headquartered in Brentwood, California, the US.

Halt Medical Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Halt Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Halt Medical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Halt Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Halt Medical Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Halt Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Halt Medical Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Halt Medical Raises US$63.3 Million In Venture Financing 10
Halt Medical Raises US$29.5 Million In Venture Financing 11
Halt Medical Raises US$0.5 Million In Venture Financing 12
Halt Medical Raises US$3 Million In Venture Financing 13
Halt Medical Raises US$15 Million In Series E Financing 14
HALT Medical Raises US$20 Million In Venture Financing 15
HALT Medical Secures US$2 Million In Series D Venture Financing 17
Halt Medical Raises US$1.3 Million In Venture Financing 18
Partnerships 19
Halt Medical Enters into Licensing Agreement with InnerOptic Technology 19
Asset Transactions 20
Acessa Health Acquires Acessa System from Halt Medical 20
Trinity Park Surgery Center Acquires Acessa Guidance System from Halt Medical 21
Halt Medical Inc – Key Competitors 22
Halt Medical Inc – Key Employees 23
Halt Medical Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Corporate Communications 25
Mar 22, 2016: Kim Bridges joins Halt Medical as President and Chief Executive Officer 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Halt Medical Inc, Medical Equipment, Key Facts 2
Halt Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Halt Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Halt Medical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Halt Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Halt Medical Inc, Deals By Market, 2011 to YTD 2017 8
Halt Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Halt Medical Raises US$63.3 Million In Venture Financing 10
Halt Medical Raises US$29.5 Million In Venture Financing 11
Halt Medical Raises US$0.5 Million In Venture Financing 12
Halt Medical Raises US$3 Million In Venture Financing 13
Halt Medical Raises US$15 Million In Series E Financing 14
HALT Medical Raises US$20 Million In Venture Financing 15
HALT Medical Secures US$2 Million In Series D Venture Financing 17
Halt Medical Raises US$1.3 Million In Venture Financing 18
Halt Medical Enters into Licensing Agreement with InnerOptic Technology 19
Acessa Health Acquires Acessa System from Halt Medical 20
Trinity Park Surgery Center Acquires Acessa Guidance System from Halt Medical 21
Halt Medical Inc, Key Competitors 22
Halt Medical Inc, Key Employees 23

★海外企業調査レポート[Halt Medical Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aareal Bank AG:企業の戦略・SWOT・財務情報
    Aareal Bank AG - Strategy, SWOT and Corporate Finance Report Summary Aareal Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Kyochon F&B Co., Ltd.
    Kyochon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kyochon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Shapoorji Pallonji & Co Pvt Ltd:企業の戦略的SWOT分析
    Shapoorji Pallonji & Co Pvt Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Alabama Municipal Electric Authority:企業の戦略的SWOT分析
    Alabama Municipal Electric Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Sodexo Inc:企業の戦略的SWOT分析
    Sodexo Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • HORNBACH Holding AG & Co. KGaA:企業の戦略・SWOT・財務情報
    HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Key Energy Services, Inc.:企業の戦略・SWOT・財務情報
    Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Y.S.P. Southeast Asia Holding Berhad (YSPSAH):企業の財務・戦略的SWOT分析
    Y.S.P. Southeast Asia Holding Berhad (YSPSAH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Zhejiang Jingxin Pharmaceutical Co Ltd (002020):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Jingxin Pharmaceutical Co Ltd (Jingxin Pharma) is a pharmaceutical company that manufactures and markets traditional Chinese medicine. The company provides products such as finished dosage forms, Chinese herbal drugs and APIs. Its finished dosage products comprise simvastatin tablet …
  • EnviroMission Limited:企業の戦略的SWOT分析
    EnviroMission Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Clover Corp Ltd (CLV):企業の財務・戦略的SWOT分析
    Summary Clover Corp Ltd (Clover), a subsidiary of Washington H. Soul Pattinson and Company Ltd, is a developer of science-based bioactives. The company offers products such as DHA oils, DHA powders and microencapsulation. It delivers bioactive ingredients through encapsulation. Clover’s refined tuna …
  • Qisda Corporation
    Qisda Corporation - Strategy, SWOT and Corporate Finance Report Summary Qisda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • International Business Machines Corporation:企業のM&A・事業提携・投資動向
    International Business Machines Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's International Business Machines Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Senju Pharmaceutical Co Ltd:企業の戦略的SWOT分析
    Senju Pharmaceutical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Logicor Europe Ltd:企業の戦略的SWOT分析
    Logicor Europe Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Saudi Basic Industries Corp (2010):企業の財務・戦略的SWOT分析
    Saudi Basic Industries Corp (2010) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • KemPharm Inc (KMPH):企業の財務・戦略的SWOT分析
    Summary KemPharm Inc (KemPharm) is a clinical-stage specialty pharmaceutical company that offers discovery and development of proprietary new molecular entity prodrugs. The company’s product pipeline includes KP415, KP484 methylphenidate drug for the treatment of attention deficit hyperactivity diso …
  • Envision Healthcare Corp:戦略・SWOT・企業財務分析
    Envision Healthcare Corp - Strategy, SWOT and Corporate Finance Report Summary Envision Healthcare Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Coresa Sa:企業の戦略・SWOT・財務分析
    Coresa Sa - Strategy, SWOT and Corporate Finance Report Summary Coresa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • China General Nuclear Power Corp (1816):企業の財務・戦略的SWOT分析
    Summary China General Nuclear Power Corp (CGN), formerly China Guangdong Nuclear Power Group (CGNPC) is a clean energy company that offers clean energy products and renewable energy services. The company's products include nuclear power and HPR1000, among others. It offers services such as nuclear p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆